Evidence map›Paper›PMID 42725411›Full record

ArticleeLife2026

PRRT2 as an auxiliary regulator of Nav channel slow inactivation.

Bin Lu, Qi-Wu Xu, Jing Zhang, Xue-Mei Wu, Jun-Yan He, Jing-Qiu Peng, Guang Yang, Ke-Xian Li, Ling Zhuang, Yu-Xian Zhang and 2 more

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bin Lu *Center for Excellence in Brain Science and Intelligence Technology (Institute of Neuroscience), Chinese Academy of Sciences, Shanghai, China.ORCID https://orcid.org/0000-0003-1456-2517
Qi-Wu Xu *Center for Excellence in Brain Science and Intelligence Technology (Institute of Neuroscience), Chinese Academy of Sciences, Shanghai, China.ORCID https://orcid.org/0000-0003-2236-8415
Jing Zhang *Center for Excellence in Brain Science and Intelligence Technology (Institute of Neuroscience), Chinese Academy of Sciences, Shanghai, China.ORCID https://orcid.org/0009-0009-4050-8486
Xue-Mei Wu *Center for Excellence in Brain Science and Intelligence Technology (Institute of Neuroscience), Chinese Academy of Sciences, Shanghai, China.ORCID https://orcid.org/0009-0000-3387-7579
Jun-Yan He *Center for Excellence in Brain Science and Intelligence Technology (Institute of Neuroscience), Chinese Academy of Sciences, Shanghai, China.ORCID https://orcid.org/0009-0002-3342-9877
Jing-Qiu PengCenter for Excellence in Brain Science and Intelligence Technology (Institute of Neuroscience), Chinese Academy of Sciences, Shanghai, China.ORCID https://orcid.org/0009-0008-1124-7726
Guang YangCenter for Excellence in Brain Science and Intelligence Technology (Institute of Neuroscience), Chinese Academy of Sciences, Shanghai, China.ORCID https://orcid.org/0009-0009-1840-8411
Ke-Xian LiDepartment of Neurology, Zhongshan Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0009-0004-5401-4923
Ling ZhuangCenter for Excellence in Brain Science and Intelligence Technology (Institute of Neuroscience), Chinese Academy of Sciences, Shanghai, China.ORCID https://orcid.org/0009-0007-6846-883X
Yu-Xian ZhangCenter for Excellence in Brain Science and Intelligence Technology (Institute of Neuroscience), Chinese Academy of Sciences, Shanghai, China.ORCID https://orcid.org/0009-0005-1796-1443
Zhi-Ying WuDepartment of Medical Genetics and Center for Rare Diseases, Second Affiliated Hospital, Zhejiang University School of Medicine and Zhejiang Key Laboratory of Rare Diseases for Precision Medicine and Clinical Translation, Hangzhou, China.ORCID https://orcid.org/0000-0003-2106-572X
Zhi-Qi XiongCenter for Excellence in Brain Science and Intelligence Technology (Institute of Neuroscience), Chinese Academy of Sciences, Shanghai, China.ORCID https://orcid.org/0000-0001-7727-8412

Funding

Innovation of Science and Technology 2030-Major Project "platform of nonhuman primate models" 2021ZD0200900National Natural Science Foundation of China 82021001National Natural Science Foundation of China 82271269
6 · The paper itself

Abstract

During sustained activity, voltage-gated sodium (Nav) channels enter a slow-inactivated state to limit cellular hyperexcitability. Disruption of this regulatory process has been implicated in skeletal, cardiac, and neurological disorders. While the kinetics of this process are well characterized, its endogenous modulators remain unclear. Here, we identify Proline-Rich Transmembrane Protein 2 (PRRT2) as a native regulator of Nav channel slow inactivation. We show that PRRT2 facilitates the entry of Nav channels into the slow-inactivated state and delays their recovery, a regulatory effect conserved from zebrafish to humans. PRRT2 forms molecular complexes with Nav channels both in vitro and in vivo. In the mouse cortex, PRRT2 deficiency impairs the slow inactivation of Nav channels in neuronal axons, leading to reduced cortical resilience in response to hyperexcitable challenges. Together, these findings establish PRRT2 as a physiological modulator of Nav channel slow inactivation and reveal a mechanism that supports cortical resilience to pathological perturbations.

Indexed as

Membrane ProteinsNerve Tissue ProteinsVoltage-Gated Sodium ChannelsAnimalsHEK293 CellsHumansMiceNeuronsZebrafishMembrane ProteinsNerve Tissue ProteinsPRRT2 protein, humanPRRT2 protein, mouseVoltage-Gated Sodium Channelscortical resiliencehyperexcitabilitymouseNav channelneurosciencePRRT2slow inactivationvoltage-gated sodium channel

Identifiers

PMID42725411
PMCPMC13568701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.